ARDELYX, INC. Inventory, Noncurrent
ARDELYX, INC. (ARDX) had Inventory, Noncurrent of $113.13 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:InventoryNoncurrent · last filed 2026-08-06
- 2026-06-30: Inventory, Noncurrent $113.13M.
- 2026-03-31: Inventory, Noncurrent $105.28M.
- 2025-12-31: Inventory, Noncurrent $105.37M.
- 2025-09-30: Inventory, Noncurrent $104.19M.
| Period end | Inventory, Noncurrent |
|---|---|
| 2026-06-30 | $113.13M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $105.28M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $105.37M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $104.19M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $100.98M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $82.10M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $70.01M 10-K · filed 2026-02-19 |
| 2024-09-30 | $73.78M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $69.68M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $69.05M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $37.04M 10-K · filed 2025-02-20 |
| 2023-09-30 | $38.97M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $40.30M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $40.12M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $25.06M 10-K · filed 2024-02-22 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |